| Crohn Disease |
1 |
0.97 |
| Psoriasis |
0 |
0.91 |
| Psoriatic Arthritis |
0 |
0.54 |
| Arthritis |
0 |
0.52 |
| Clinical Research |
0 |
0.52 |
| Plaque Psoriasis |
0 |
0.52 |
| Food and Drug Administration (FDA) |
0 |
0.35 |
| Healthcare and Medical Technology |
0 |
0.25 |
| Biologic Therapy |
0 |
0.17 |
| Interleukin |
0 |
0.17 |
| Intravenous |
0 |
0.17 |
| Monoclonal Antibody |
0 |
0.17 |
| New York |
0 |
0.17 |
| Inflammatory Bowel Disease |
0 |
0.09 |